Skip to main content

Cervical Cancer Clinical Trials

Review the cervical cancer clinical trials on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 76-100 of 156

A Study of MGC026 in Participants With Advanced Solid Tumors
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
Three Fraction Brachytherapy versus Four Fraction Brachytherapy for the Treatment of Cervical Cancer, BRACHY-FIT Trial
Status: Active
Location: Stanford Cancer Institute Palo Alto, Palo Alto, California
Physical Therapy and Coping Skills Training for Improving Women's Sexual Function after Pelvic Radiation
Status: Active
Location: Duke University Medical Center, Durham, North Carolina
Magnetic Resonance Imaging-Guided Brachytherapy in Treating Patients with Gynecologic Cancers
Status: Active
Location: Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland
Tri-weekly Cisplatin Based Chemoradiation in Locally Advanced Cervical Cancer
Status: Active
Location: See ClinicalTrials.gov
Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (eVOLVE-Cervical)
Status: Active
Location: Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia
PRGN-2009 in Combination With Pembrolizumab Versus Pembrolizumab in Patients With Recurrent or Metastatic Cervical Cancer
Status: Active
Location: Fred Hutch/University of Washington/Seattle Children's Cancer Consortium, Seattle, Washington
Oral Axl/Mer/CSF1R Selective Tyrosine Kinase Inhibitor Q702 in Combination With Pembrolizumab in Patients With Selected Advanced Solid Tumors
Status: Active
Location: See ClinicalTrials.gov
Study of SGN1 Administered Via Intratumoral Injection in Patients With Advanced Solid Tumor
Status: Active
Location: See ClinicalTrials.gov
Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067
Status: Active
Location: See ClinicalTrials.gov
A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4
Status: Active
Location: 2 locations
Study of COTI-2 as Monotherapy or Combination Therapy for the Treatment of Malignancies
Status: Active
Location: See ClinicalTrials.gov
A Study of DF6002 Alone and in Combination With Nivolumab
Status: Active
Location: See ClinicalTrials.gov
FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery
Status: Active
Location: See ClinicalTrials.gov
Curcumin for the Treatment of Patients with Cervical Intraepithelial Neoplasia
Status: Approved
Location: Grady Health System, Atlanta, Georgia
Telaglenastat and Chemoradiotherapy for the Treatment of Advanced Cervical Cancer
Status: Approved
Location: Siteman Cancer Center at Washington University, Saint Louis, Missouri
A Study of NPX267 for Subjects With Solid Tumors Known to Express HHLA2/B7-H7
Status: Temporarily Closed to Accrual
Location: Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland
Vudalimab for the Treatment of Advanced Rare Cancers
Status: Temporarily Closed to Accrual
Location: M D Anderson Cancer Center, Houston, Texas
Atezolizumab and Bevacizumab in Treating Patients with Rare Solid Tumors
Status: Temporarily Closed to Accrual
Location: M D Anderson Cancer Center, Houston, Texas
Distance-Based Exercise to Preserve Function and Prevent Disability (DEFEND)
Status: Active
Location: 14 locations
Cryocompression with or without Cilostazol for the Prevention of Paclitaxel-induced Neuropathy in Patients with Gynecological Cancers
Status: Active
Location: 4 locations
Pre-Rehabilitation Pelvic Physical Therapy for Reducing Pelvic Pain and Improving Sexual Function in Female Patients Undergoing Pelvic Radiotherapy
Status: Active
Location: IU Health North Hospital, Carmel, Indiana
Patient-Tailored Physical Activity to Improve Health and Survival in Older Women with Gynecologic Cancers Undergoing Chemotherapy, Fit4Treatment Trial
Status: Active
Location: Northwestern University, Chicago, Illinois
An Educational Intervention (Starting the Conversation) to Promoting Effective Clinical Communication about Sexual Health for Patients with Gynecologic Cancer
Status: Active
Location: Fox Chase Cancer Center, Philadelphia, Pennsylvania
Dosing Physical Activity Among Older Cancer Survivors Who Experience Chronic Pain: a Micro-randomized Trial
Status: Active
Location: Medical College of Wisconsin, Milwaukee, Wisconsin